Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis
Comenzo, R L, Reece, D, Palladini, G, Seldin, D, Sanchorawala, V, Landau, H, Falk, R, Wells, K, Solomon, A, Wechalekar, A, Zonder, J, Dispenzieri, A, Gertz, M, Streicher, H, Skinner, M, Kyle, R A, Merlini, G
Published in Leukemia (01.11.2012)
Published in Leukemia (01.11.2012)
Get full text
Journal Article
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma
Palumbo, A, Rajkumar, S V, Dimopoulos, M A, Richardson, P G, San Miguel, J, Barlogie, B, Harousseau, J, Zonder, J A, Cavo, M, Zangari, M, Attal, M, Belch, A, Knop, S, Joshua, D, Sezer, O, Ludwig, H, Vesole, D, Bladé, J, Kyle, R, Westin, J, Weber, D, Bringhen, S, Niesvizky, R, Waage, A, von Lilienfeld-Toal, M, Lonial, S, Morgan, G J, Orlowski, R Z, Shimizu, K, Anderson, K C, Boccadoro, M, Durie, B G, Sonneveld, P, Hussein, M A
Published in Leukemia (01.02.2008)
Published in Leukemia (01.02.2008)
Get full text
Journal Article
Carfilzomib in multiple myeloma patients with renal impairment: pharmacokinetics and safety
Badros, A Z, Vij, R, Martin, T, Zonder, J A, Kunkel, L, Wang, Z, Lee, S, Wong, A F, Niesvizky, R
Published in Leukemia (01.08.2013)
Published in Leukemia (01.08.2013)
Get full text
Journal Article
Treatment outcomes in patients with relapsed and refractory multiple myeloma and high-risk cytogenetics receiving single-agent carfilzomib in the PX-171-003-A1 study
Jakubowiak, A J, Siegel, D S, Martin, T, Wang, M, Vij, R, Lonial, S, Trudel, S, Kukreti, V, Bahlis, N, Alsina, M, Chanan-Khan, A, Buadi, F, Reu, F J, Somlo, G, Zonder, J, Song, K, Stewart, A K, Stadtmauer, E, Harrison, B L, Wong, A F, Orlowski, R Z, Jagannath, S
Published in Leukemia (01.12.2013)
Published in Leukemia (01.12.2013)
Get full text
Journal Article
NUCLEAR EXPORT INHIBITION ENHANCES THE ACTIVITY OF R‐CHOP IN NON‐HODGKIN'S LYMPHOMA
Azmi, A.S., Seymour, E., Muqbil, I., Aboukameel, A., Bhutani, D., Zonder, J., Ramchandran, R., Yang, J.
Published in Hematological oncology (01.06.2019)
Published in Hematological oncology (01.06.2019)
Get full text
Journal Article
P56 SURVIVAL BENEFIT OF BIRTAMIMAB IN MAYO STAGE IV AL AMYLOIDOSIS IN THE PHASE 3 VITAL STUDY WAS CONSISTENT ACROSS ALL KEY BASELINE VARIABLES
Gertz, M., Cohen, A., Comenzo, R., Kastritis, E., Landau, H., Libby, E., Liedtke, M., Sanchorawala, V., Schönland, S., Wechalekar, A., Ando, Y., Koh, Y., Zonder, J., Palladini, G., Nie, C., Karp, C., Jin, Y., Conrad, A., Kinney, G., Merlini, G.
Published in HemaSphere (09.05.2023)
Published in HemaSphere (09.05.2023)
Get full text
Journal Article
PB1820: CD47‐BLOCKER TTI‐622 COMBINED WITH AZACITIDINE IN PATIENTS WITH TP53‐MUTATED ACUTE MYELOID LEUKEMIA (AML) AND WITH AZACITIDINE + VENETOCLAX IN ELDERLY OR UNFIT PATIENTS WITH TP53‐WILDTYPE AML
Daver, N., Maris, M., Ramchandren, R., Bixby, D., Doucette, K., Mawad, R., Egan, D., Stevens, D., Zonder, J., Molloy, N., Scheuber, A., Bruns, I., Mantzaris, I., Konopleva, M., Goldberg, A. D.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
P965: FOLLOW‐UP ANALYSIS OF THE RANDOMIZED PHASE II TRIAL OF BORTEZOMIB, LENALIDOMIDE, DEXAMTHASONE WITH/WITHOUT ELOTUZUMAB FOR NEWLY DIAGNOSED, HIGH RISK MULTIPLE MYELOMA (SWOG‐1211)
Usmani, S., Hoering, A., Ailawadhi, S., Sexton, R., Lipe, B., Valent, J., Rosenzweig, M., Zonder, J., Dhodapkar, M., Callander, N., Zimmerman, T., Voorhees, P., Durie, B., Rajkumar, S. V., Richardson, P., Orlowski, R.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
Phase I safety data of lenalidomide, bortezomib, dexamethasone, and elotuzumab as induction therapy for newly diagnosed symptomatic multiple myeloma: SWOG S1211
Usmani, S Z, Sexton, R, Ailawadhi, S, Shah, J J, Valent, J, Rosenzweig, M, Lipe, B, Zonder, J A, Fredette, S, Durie, B, Hoering, A, Bartlett, B, Orlowski, R Z
Published in Blood cancer journal (New York) (07.08.2015)
Published in Blood cancer journal (New York) (07.08.2015)
Get full text
Journal Article
The role of vertebral augmentation in multiple myeloma: International Myeloma Working Group Consensus Statement
Hussein, M A, Vrionis, F D, Allison, R, Berenson, J, Berven, S, Erdem, E, Giralt, S, Jagannath, S, Kyle, R A, LeGrand, S, Pflugmacher, R, Raje, N, Rajkumar, S V, Randall, L, Roodman, D, Siegel, D, Vescio, R, Zonder, J, Durie, B G M
Published in Leukemia (01.08.2008)
Published in Leukemia (01.08.2008)
Get full text
Journal Article
Phase 1, multicenter, open-label, dose-escalation, combination study (NCT02103335) of pomalidomide (POM), marizomib (MRZ, NPI-0052), and dexamethasone (DEX) in patients with relapsed and refractory multiple myeloma (MM); study NPI-0052-107 preliminary results
Spencer, A, Badros, A, Laubach, J, Harrison, S, Zonder, J, Chauhan, D, Anderson, K, Reich, S, Trikha, M, Richardson, P
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Get full text
Journal Article
Oprozomib (OPZ) and Dexamethasone (DEX) in Patients (Pts) With Relapsed and/or Refractory Multiple Myeloma (RRMM): Updated Results From a Phase 1b/2, Multicenter, Open-Label Study
Prada, C.P, Shain, K.H, Voorhees, P, Gabrail, N, Abidi, M, Zonder, J, Boccia, R, Richardson, P.G, Neuman, L, Wong, H, Dixon, S, Hari, P
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Get full text
Journal Article
First randomized trial comparing balloon kyphoplasty (BKP) to non-surgical management among cancer patients with vertebral compression fractures
Bastian, L, Pflügmacher, R, Berenson, J.R, Jarzem, P, Zonder, J, Tillman, J.B, Ashraf, T, Vrionis, F.D
Published in Bone (New York, N.Y.) (01.01.2011)
Published in Bone (New York, N.Y.) (01.01.2011)
Get full text
Journal Article
S175: ATLAS: A PHASE 3 RANDOMIZED TRIAL OF CARFILZOMIB, LENALIDOMIDE, AND DEXAMETHASONE VERSUS LENALIDOMIDE ALONE AFTER STEM‐CELL TRANSPLANT FOR MULTIPLE MYELOMA
Dytfeld, D., Wróbel, T., Jamroziak, K., Kubicki, T., Robak, P., Walter‐Croneck, A., Czyż, J., Tyczyńska, A., Druzd‐Sitek, A., Giannopoulos, K., Nowicki, A., Szczepaniak, T., Łojko‐Dankowska, A., Matuszak, M., Gil, L., Puła, B., Rybka, J., Majcherek, M., Usnarska‐Zubkiewicz, L., Szukalski, L., Końska, A., Zaucha, J. M., Walewski, J., Mikulski, D., Czabak, O., Robak, T., Grzybowska, U., Lahoud, O. B., Zonder, J. A., Griffith, K., Stefka, A., Major, A., Derman, B. A., Jakubowiak, A. J.
Published in HemaSphere (01.06.2022)
Published in HemaSphere (01.06.2022)
Get full text
Journal Article
The role of vertebral augmentation in multiple myeloma: International Myeloma Working Group Consensus Statement
Erdem, E, Randall, R.L, Raje, N, Jagannath, S, Durie, B.G.M, Berven, S, Rajkumar, S.V, Pflugmacher, R, Roodman, D, Hussein, M.A, Vrionis, F.D, Zonder, J, Berenson, J, LeGrand, S, Siegel, D, Kyle, R.A, Giralt, S, Vescio, R, Allison, R
Published in Leukemia (01.08.2008)
Published in Leukemia (01.08.2008)
Get full text
Journal Article
Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis
Kastritis, Efstathios, Palladini, Giovanni, Minnema, Monique C, Wechalekar, Ashutosh D, Jaccard, Arnaud, Lee, Hans C, Sanchorawala, Vaishali, Gibbs, Simon, Mollee, Peter, Venner, Christopher P, Lu, Jin, Schönland, Stefan, Gatt, Moshe E, Suzuki, Kenshi, Kim, Kihyun, Cibeira, M. Teresa, Beksac, Meral, Libby, Edward, Valent, Jason, Hungria, Vania, Wong, Sandy W, Rosenzweig, Michael, Bumma, Naresh, Huart, Antoine, Dimopoulos, Meletios A, Bhutani, Divaya, Waxman, Adam J, Goodman, Stacey A, Zonder, Jeffrey A, Lam, Selay, Song, Kevin, Hansen, Timon, Manier, Salomon, Roeloffzen, Wilfried, Jamroziak, Krzysztof, Kwok, Fiona, Shimazaki, Chihiro, Kim, Jin-Seok, Crusoe, Edvan, Ahmadi, Tahamtan, Tran, NamPhuong, Qin, Xiang, Vasey, Sandra Y, Tromp, Brenda, Schecter, Jordan M, Weiss, Brendan M, Zhuang, Sen H, Vermeulen, Jessica, Merlini, Giampaolo, Comenzo, Raymond L
Published in The New England journal of medicine (01.07.2021)
Published in The New England journal of medicine (01.07.2021)
Get full text
Journal Article
S189: EARLY, DEEP, AND DURABLE RESPONSES, AND LOW RATES OF CRS WITH REGN5458, A BCMAXCD3 BISPECIFIC ANTIBODY, IN A PHASE 1/2 FIRST-IN-HUMAN STUDY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
Zonder, J. A., Richter, J., Bumma, N., Brayer, J., Hoffman, J. E., Bensinger, W. I., Wu, K. L., Xu, L., Chokshi, D., Boyapati, A., Cronier, D., Houvras, Y., Rodriguez Lorenc, K., Kroog, G. S., Dhodapkar, M. V., Lentzsch, S., Cooper, D., Jagannath, S.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article